Core Viewpoint - Suzhou Haofan Biological Co., Ltd. has approved the cancellation of 16,000 unvested restricted stocks due to three incentive recipients leaving the company for personal reasons, which will not materially affect the company's financial status or operational results [3][4]. Summary by Sections 1. Decision-Making Process and Disclosure - The company held meetings to review and approve the 2024 Restricted Stock Incentive Plan and its related proposals, which were passed by the Board of Directors and the Compensation and Assessment Committee [1][2]. 2. Verification by Supervisory Board - The Supervisory Board verified the list of incentive recipients and issued opinions on the related matters, confirming no objections were raised during the public notice period [2]. 3. Cancellation of Restricted Stocks - The cancellation of 16,000 restricted stocks was due to three individuals no longer qualifying as incentive recipients, as per the regulations outlined in the management measures and the incentive plan [3][4]. 4. Impact on the Company - The cancellation of these restricted stocks is not expected to have a significant impact on the company's financial condition or operational results, nor will it affect the stability of the core team or the implementation of the stock incentive plan [4]. 5. Opinions from Committees and Legal Advisors - The Compensation and Assessment Committee and legal advisors confirmed that the cancellation complies with relevant laws and regulations, and does not harm the interests of the company or its shareholders [5].
昊帆生物: 关于作废部分已授予尚未归属的限制性股票的公告